Related Experiment Videos
Heterotopic Ossification Following Upper Extremity Injury
Shailesh Agarwal1, Shawn Loder1, Benjamin Levi1
1Section of Plastic Surgery, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA.
Hand Clinics
|April 2, 2017
Summary
Heterotopic ossification (HO) is a major hurdle in burn and trauma recovery. Current treatments like surgery and NSAIDs are insufficient, prompting research into new prevention strategies targeting bone morphogenetic protein pathways.
Area of Science:
- Orthopedics
- Regenerative Medicine
- Biomaterials
Background:
- Heterotopic ossification (HO) significantly impedes rehabilitation after severe burns or trauma.
- Surgical excision, a primary treatment, fails to resolve chronic issues like pain, contractures, and nerve dysfunction.
- Existing therapies focus on excision and recurrence prevention via NSAIDs or radiation.
Purpose of the Study:
- To explore novel therapeutic strategies for preventing the initial occurrence of heterotopic ossification.
- To investigate the role of nonsteroidal anti-inflammatory drugs (NSAIDs) in HO prevention.
- To identify new inhibitors targeting the bone morphogenetic protein (BMP) signaling pathway for HO management.
Main Methods:
- Review of current literature on heterotopic ossification treatments.
- Analysis of the efficacy of NSAIDs in preventing HO.
- Exploration of emerging research on BMP pathway inhibitors.
Main Results:
- Surgical excision does not address chronic sequelae of HO.
- NSAIDs and radiation therapy are used for recurrence prevention.
- Novel inhibitors of the BMP signaling pathway are under investigation for primary HO prevention.
Conclusions:
- Current HO management is limited in addressing chronic complications.
- Further research into NSAIDs and BMP pathway inhibitors is crucial for developing effective prevention strategies.
- Targeting the BMP pathway offers a promising avenue for future HO therapies.